Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece.
J Biomed Nanotechnol. 2009 Aug;5(4):409-15. doi: 10.1166/jbn.2009.1050.
The haemolysis caused by various types of liposomes was measured after incubation of liposomes with human red blood cell (erythrocyte) suspension. Liposomes composed of phospholipids and containing or not arsonolipids (arsonoliposomes) were tested. In some cases liposomes that were coated with polyethylene glycol (MW 2000), which were formulated by including 8 mol% DSPE-PEG2000 in their lipid membrane, were used. Multilamellar vesicles were prepared by the thin film hydration technique (conventional liposomes) or by the one-step technique (arsonoliposomes). Sonicated vesicles were produced by probe sonication of the initial liposome preparations. Phospholipid concentration in the liposome dispersions were measured by the Stewart assay, and adjusted accordingly. Haemolysis was measured after incubating 100 microl of liposome dispersions with 900 microl of red blood cell suspension (blood) for 1 h. The results reveal that the haemolysis caused, when liposomes are incubated in blood at concentrations below 0.16 mg (lipid)/ml (blood), was minimum. Only in case of Pegylated arsonoliposomes, significant haemolysis percents were observed. At higher lipid concentrations, 0.38 or 0.6 mg/ml, the haemolysis caused by arsonoliposomes was substantially increased, even in the cases of non-Pegylated arsonoliposomes. In most cases, especially when arsonolipid-containing liposomes were evaluated, vesicle size also had considerable effect on vesicle-induced haemolysis. Nevertheless, at concentrations which are relevant with liposomal drug administration in humans, all formulations tested demonstrated negligible haemolysis.
将脂质体与人类红细胞(红细胞)悬浮液孵育后,测量各种类型脂质体引起的溶血。测试了由磷脂组成且含有或不含有芳基脂质(芳基脂质体)的脂质体。在某些情况下,使用了用聚乙二醇(MW 2000)涂覆的脂质体(MW 2000),其通过在脂质膜中包含 8 mol%DSPE-PEG2000 来配制。通过薄膜水合技术(常规脂质体)或一步法(芳基脂质体)制备多层囊泡。通过初始脂质体制备物的探针超声处理产生超声处理的囊泡。通过斯图尔特测定法测量脂质体分散体中的磷脂浓度,并进行相应调整。将 100 微升脂质体分散体与 900 微升红细胞悬浮液(血液)孵育 1 小时后,测量溶血。结果表明,当脂质体在低于 0.16 mg(脂质)/ml(血液)的浓度下在血液中孵育时,引起的溶血最小。仅在 Pegylated 芳基脂质体的情况下,观察到明显的溶血百分比。在较高的脂质浓度(0.38 或 0.6 mg/ml)下,芳基脂质体引起的溶血大大增加,即使在未 Pegylated 的芳基脂质体的情况下也是如此。在大多数情况下,特别是在评估含有芳基脂质的脂质体时,囊泡大小对囊泡诱导的溶血也有相当大的影响。尽管如此,在与人类脂质体给药相关的浓度下,所有测试的制剂均表现出可忽略不计的溶血。